Terrain Bio

Cambridge, United States

Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.

$9.0M raised

Feb 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Terrain Bio raised?

Terrain Bio has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.

Who are Terrain Bio's investors?

Terrain Bio's investors include Bruker, Olive Capital, Brainstorm Ventures, Uncommon Denominator, Hawktail Management.

Where is Terrain Bio headquartered?

Terrain Bio is headquartered in Cambridge, United States.

What does Terrain Bio do?

Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.

What stage is Terrain Bio at?

Terrain Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 12, 2025.

MLA

"Terrain Bio — Funding & Investors." VCBacked, February 12, 2025, https://www.vcbacked.co/company/terrain-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). Terrain Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/terrain-bio

Wikipedia (cite web)

{{cite web |title=Terrain Bio — Funding & Investors |url=https://www.vcbacked.co/company/terrain-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 12, 2025.